Attribution Key: Unrelated 1 The adverse event (toxicity) is not related to the investigational agent(s). Page 1 of 3 Unlikely 2 The adverse event (toxicity) is doubtfully related to the investigational agent(s). Revised

First Page		Document Content
Date: 2008-05-28 21:39:37 Oncology Transfusion medicine Febrile neutropenia Neutropenia Thrombocytopenia Platelet Bleeding Fever Mucositis Medicine Biology Blood		Attribution Key: Unrelated 1 The adverse event (toxicity) is not related to the investigational agent(s). Page 1 of 3 Unlikely 2 The adverse event (toxicity) is doubtfully related to the investigational agent(s). Revised Add to Reading List Source URL: ctep.cancer.gov Download Document from Source Website File Size: 167,00 KB Share Document on Facebook

	November 21, 2016 U.S. FDA Grants Fast Track Designation for the Development of Oragenics’ AG013 for Oral Mucositis TAMPA, Fla.--(BUSINESS WIRE)-- Oragenics (NYSE:MKT - OGEN.BC), a leader in the DocID: 1sTuF - View Document
	Overview ActoBiotics® Platform: A Novel Class of Oral Biotherapeutics DocID: 1rtnN - View Document
	OF THE A Professional Guide for the Management of Patients Undergoing Chemotherapy and Head and Neck Radiation Therapy DocID: 1qXFO - View Document
	Oral Health, Cancer, and the Quality of Life Penn Dental Medicine’s Department of Oral Medicine and the University’s Abramson Cancer Center join forces in a powerful health care partnership. by juliana delany DocID: 1qDA8 - View Document
	Fifteen Things Nurses and Patients Should Question Don’t automatically initiate continuous electronic fetal heart rate (FHR) monitoring during labor for women without risk factors; consider intermittent auscultation (I DocID: 1pkjO - View Document